benoxinate hydrochloride 4 MG/ML / fluorescein sodium 2.5 MG/ML Ophthalmic Solution
RxNorm concept 2099132, clinical drug (scd). Prescribable name: benoxinate HCl 0.4 % / fluorescein sodium 0.25 % Ophthalmic Solution.
- RxCUI
- 2099132
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2099132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
benoxinate hydrochloride 0.4 % / fluorescein sodium 0.25 % Ophthalmic Drops
Related concepts
- fluorescein sodium 2.5 MG/ML (SCDC, consists of)
- benoxinate hydrochloride 4 MG/ML (SCDC, consists of)
- Ophthalmic Solution (DF, has dose form)
- benoxinate hydrochloride 4 MG/ML / fluorescein sodium 2.5 MG/ML Ophthalmic Solution [Altafluor] (SBD, has tradename)
Linked data
NDCs
- 17238050105
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2099132 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2099132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2099132. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.